Horizon Technology Finance Provides $12.5 Million Venture Loan Facility to Sonex Health
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced a $12.5 million venture loan facility to Sonex Health, Inc., with an initial funding of $7.5 million. Sonex develops innovative ultrasound-guided procedure technologies, notably the SX-One MicroKnife, which is FDA cleared for treating Carpal Tunnel Syndrome (CTS). This device allows for a less invasive procedure in outpatient settings, significantly reducing recovery time. The loan will support Sonex's working capital and growth initiatives, enhancing their ability to market the SX-One MicroKnife and develop new medical solutions.
- Horizon provided a $12.5 million loan facility to Sonex Health.
- Initial funding of $7.5 million completed.
- SX-One MicroKnife is FDA cleared, enabling outpatient treatment for CTS.
- The loan supports Sonex's marketing and development of new medical solutions.
- None.
FARMINGTON, Conn., Nov. 17, 2020 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today it has provided a
Sonex develops innovative technology, education and training programs for ultrasound guided procedures that reduce invasiveness, improve safety and lower the cost of quality care. Sonex's first device, the SX-One MicroKnife®, is FDA 510k cleared and is the first major technological advance in treating Carpal Tunnel Syndrome (CTS) in 20 years. CTS affects approximately
"Sonex's innovative SX-One MicroKnife provides physicians with a clear alternative to treat CTS," said Gerald A. Michaud, President of Horizon. "We are excited to support Sonex Health's growth initiatives, as well as launching additional therapeutic devices to treat other common medical conditions."
"We are very appreciative of Horizon's support of Sonex, and its clear understanding of how the innovative SX-One Microknife is a game-changer for those who suffer with CTS," said Dr. Darryl Barnes, Chief Executive Officer of Sonex. "Physicians are able to safely and effectively perform CTR with real time ultrasound guidance, considerably reducing recovery time for patients and freeing up operating room availability for other procedures. Horizon's support allows us to further market the SX-One MicroKnife and strengthen our efforts to develop new solutions that lower the cost of quality care for treating additional widespread conditions."
About Horizon Technology Finance
Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of Horizon is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Headquartered in Farmington, Connecticut, Horizon also has regional offices in Pleasanton, California and Reston, Virginia. To learn more, please visit www.horizontechfinance.com.
About Sonex Health, Inc.
Sonex Health was founded by Mayo Clinic physicians Darryl Barnes and Jay Smith along with business operations expert Aaron Keenan in 2014. The three were brought together by a shared desire to create safe and effective treatments for common orthopedic conditions that would improve the patient experience and practice efficiency while reducing costs. Sonex Health has developed the SX-One MicroKnife with Meerkat Technology® to treat carpal tunnel syndrome in a novel fashion. This innovation allows carpal tunnel release, a procedure that once took place in an operating room, to be safely and effectively performed through a small incision (<5mm) in a procedure room or office setting, resulting in rapid patient recovery and reduced costs. For more information, visit www.sonexhealth.com and follow Sonex Health on Twitter, Facebook and LinkedIn.
Forward-Looking Statements
Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in the Company's filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Contacts:
Investor Relations:
ICR
Garrett Edson
ir@horizontechfinance.com
(860) 284-6450
Media Relations:
ICR
Chris Gillick
HorizonPR@icrinc.com
(646) 677-1819
View original content:http://www.prnewswire.com/news-releases/horizon-technology-finance-provides-12-5-million-venture-loan-facility-to-sonex-health-301175282.html
SOURCE Horizon Technology Finance Corporation
FAQ
What is the amount of the loan provided by Horizon Technology Finance to Sonex Health?
How much of the loan to Sonex Health has been funded initially?
What is the SX-One MicroKnife developed by Sonex Health?
What will Sonex Health use the loan proceeds for?
When was the loan announcement made by Horizon Technology Finance?
